118 related articles for article (PubMed ID: 38160571)
21. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
[TBL] [Abstract][Full Text] [Related]
22. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013.
Oelofse D; Truter I
Cancer Epidemiol; 2018 Apr; 53():166-171. PubMed ID: 29462765
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive study of the epidemiology of haematological malignancies in North Queensland.
Nath K; Boles R; Emeto TI; Adegboye OA; Castellanos ME; Alele FO; Pearce J; Ewart B; Ward K; Lai HC; Morris E; Hodges G; Irving I
Intern Med J; 2023 Apr; 53(4):540-549. PubMed ID: 34668307
[TBL] [Abstract][Full Text] [Related]
24. Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN).
Pla C; Solans M; Ameijide A; Sanvisens A; Carulla M; Rojas MD; Alemán MA; Sáez-Lloret I; Díaz-Del-Campo C; Marcos-Navarro AI; Sainz-de-Aja L; Aizpurua-Atxega A; Lopez-de-Munain A; Sánchez MJ; Perucha J; Franch P; Chirlaque MD; Guevara M; Galceran J; Merino S; Marcos-Gragera R;
Front Oncol; 2022; 12():1046307. PubMed ID: 36508554
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
Sant M; Vener C; Lillini R; Rossi S; Bonfarnuzzo S; Marcos-Gragera R; Maynadié M; Innos K; Paapsi K; Visser O; Bernasconi A; Demuru E; Di Benedetto C; Mousavi SM; Blum M; Went P; Serraino D; Bennett D; Sánchez MJ; De Angelis R;
Lancet Oncol; 2024 May; ():. PubMed ID: 38703784
[TBL] [Abstract][Full Text] [Related]
26. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
Jayasekara H; Karahalios A; Juneja S; Thursfield V; Farrugia H; English DR; Giles GG
Leuk Lymphoma; 2010 Mar; 51(3):456-68. PubMed ID: 20141433
[TBL] [Abstract][Full Text] [Related]
27. Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy.
Mohammadi M; Song H; Cao Y; Glimelius I; Ekbom A; Ye W; Smedby KE
Scand J Gastroenterol; 2016; 51(5):583-9. PubMed ID: 26652908
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
29. Sex ratios and the risks of haematological malignancies.
Cartwright RA; Gurney KA; Moorman AV
Br J Haematol; 2002 Sep; 118(4):1071-7. PubMed ID: 12199787
[TBL] [Abstract][Full Text] [Related]
30. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.
Yoon SO; Suh C; Lee DH; Chi HS; Park CJ; Jang SS; Shin HR; Park BH; Huh J
Am J Hematol; 2010 Oct; 85(10):760-4. PubMed ID: 20806229
[TBL] [Abstract][Full Text] [Related]
31. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
32. Differences in incidence and trends of haematological malignancies in Japan and the United States.
Chihara D; Ito H; Matsuda T; Shibata A; Katsumi A; Nakamura S; Tomotaka S; Morton LM; Weisenburger DD; Matsuo K
Br J Haematol; 2014 Feb; 164(4):536-45. PubMed ID: 24245986
[TBL] [Abstract][Full Text] [Related]
33. Incidence of haematological malignancies by ethnic group in England, 2001-7.
Shirley MH; Sayeed S; Barnes I; Finlayson A; Ali R
Br J Haematol; 2013 Nov; 163(4):465-77. PubMed ID: 24033296
[TBL] [Abstract][Full Text] [Related]
34. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.
Smith A; Roman E; Howell D; Jones R; Patmore R; Jack A;
Br J Haematol; 2010 Mar; 148(5):739-53. PubMed ID: 19958356
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
36. Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).
Nkanga MSN; Longo-Mbenza B; Adeniyi OV; Ngwidiwo JB; Katawandja AL; Kazadi PRB; Nzonzila AN
BMC Cancer; 2017 Aug; 17(1):559. PubMed ID: 28835214
[TBL] [Abstract][Full Text] [Related]
37. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.
De Angelis R; Minicozzi P; Sant M; Dal Maso L; Brewster DH; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A;
Eur J Cancer; 2015 Oct; 51(15):2254-2268. PubMed ID: 26421827
[TBL] [Abstract][Full Text] [Related]
38. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
39. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.
Strongman H; Gadd S; Matthews A; Mansfield KE; Stanway S; Lyon AR; Dos-Santos-Silva I; Smeeth L; Bhaskaran K
Lancet; 2019 Sep; 394(10203):1041-1054. PubMed ID: 31443926
[TBL] [Abstract][Full Text] [Related]
40. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
